信达这波赢得很舒服了

Ofweek光电信息网
Feb 11

作者| 方乔编辑| 汪戈伐一场88.5亿美元的交易,给了市场不小的刺激。信达生物2月8日公告,与礼来制药达成第七次战略合作。这次协议与以往不同,信达负责从靶点发现到临床二期的全流程研发,礼来获得除大中华区外的全球商业化权益。信达将拿到3.5亿美元首付款和最高85亿美元的里程碑付款,还保留海外销售分成。消息公布次日,信达股价涨7.42%,收于85.40港元。这笔交易的特殊之处在于合作模式,跨国药企与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10